(Q43438833)

23 November 2017

title

Necrotizing soft tissue infections in the intensive care unit (English)

1 reference

23 November 2017

1 reference

Ho H. Phan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724879

20 June 2024

Christine S. Cocanour

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724879

20 June 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

full work available at URL

23 November 2017

http://journals.lww.com/00003246-201009001-00007

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

published in

Critical Care Medicine

1 reference

23 November 2017

volume

38

1 reference

23 November 2017

issue

9 Suppl

1 reference

23 November 2017

page(s)

S460-8

1 reference

Hippocrates on necrotising fasciitis

23 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Cellulitis incidence in a defined population

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing fasciitis: current concepts and review of the literature

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Skin and soft tissue infections

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

8

4

589

Fournier

1883

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

PROGRESSIVE GANGRENOUS INFECTION OF THE SKIN AND SUBCUTANEOUS TISSUES, FOLLOWING OPERATION FOR ACUTE PERFORATIVE APPENDICITIS: A STUDY IN SYMBIOSIS

20 June 2024

11

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Diagnosis of Meleney's synergistic gangrene

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Severe soft tissue infections

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

The microbiology of necrotizing soft tissue infections

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Treatment of necrotizing soft tissue infections. The need for a new approach

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing fasciitis secondary to diverticulitis.

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Predictors of mortality and limb loss in necrotizing soft tissue infections

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Otolaryngologic critical care

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

Ludwig's angina

23

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Ludwig's angina: Case report and review

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

Ludwig angina

25

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

Necrotising fasciitis

28

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program.

20 June 2024

29

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis

20 June 2024

30

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Community-associated methicillin-resistant Staphylococcus aureus

20 June 2024

31

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom

20 June 2024

32

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users

20 June 2024

33

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock

20 June 2024

34

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Clostridium septicum and malignancy

20 June 2024

35

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species

20 June 2024

36

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia

20 June 2024

38

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review

20 June 2024

39

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Systemic Vibrio infection presenting as necrotizing fasciitis and sepsis. A series of thirteen cases

20 June 2024

40

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Aeromonas bacteremia: review of 59 episodes.

20 June 2024

41

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

20 June 2024

43

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Mucormycosis in trauma patients

20 June 2024

44

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft tissue lesions after a volcanic cataclysm

20 June 2024

45

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Mucormycosis: emerging prominence of cutaneous infections

20 June 2024

46

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Zygomycosis (mucormycosis): emerging clinical importance and new treatments

20 June 2024

48

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies

20 June 2024

49

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis

20 June 2024

50

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Determinants of mortality for necrotizing soft-tissue infections

20 June 2024

51

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

20 June 2024

52

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Synergistic Necrotizing Cellulitis

20 June 2024

53

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment

20 June 2024

54

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing Soft Tissue Infections: A Guide to Early Diagnosis and Initial Therapy

20 June 2024

55

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft-tissue infections

20 June 2024

56

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft tissue infections. Risk factors for mortality and strategies for management

20 June 2024

57

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation

20 June 2024

58

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users

20 June 2024

59

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome

20 June 2024

60

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft-tissue infections

20 June 2024

61

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs.

20 June 2024

64

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

20 June 2024

65

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections

20 June 2024

66

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Laboratory risk indicator for necrotizing fasciitis score and the outcomes

20 June 2024

67

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre.

20 June 2024

68

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection

20 June 2024

69

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Magnetic resonance imaging differentiates between necrotizing and non-necrotizing fasciitis of the lower extremity

20 June 2024

70

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment.

20 June 2024

71

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Fine-needle aspiration biopsy in diagnosis of soft tissue infections

20 June 2024

72

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Invasive group A streptococcal infection: New concepts in antibiotic treatment

20 June 2024

73

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus

20 June 2024

74

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA

20 June 2024

75

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy

20 June 2024

76

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

20 June 2024

77

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

20 June 2024

78

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Treatment of complicated skin and soft tissue infections

20 June 2024

79

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

20 June 2024

80

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

20 June 2024

81

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

20 June 2024

83

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage

20 June 2024

84

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

20 June 2024

85

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy

20 June 2024

86

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

20 June 2024

88

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

20 June 2024

89

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Clinical significance of untreated Candida species isolated from ascites in cirrhotic patients

20 June 2024

90

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy

20 June 2024

91

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

Necrotizing fasciitis

92

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Fournier's gangrene: therapeutic impact of hyperbaric oxygen

20 June 2024

93

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Hyperbaric oxygen for the treatment of fournier's gangrene

20 June 2024

96

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?

20 June 2024

97

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection

20 June 2024

98

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Surgical reconstruction of the sequelae of penile and scrotal gangrene: a plea for simplicity

20 June 2024

99

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Gracilis musculocutaneous flap scrotal reconstruction after Fournier gangrene

20 June 2024

100

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

More than 10 years of experience with reconstructed scrotums

20 June 2024

101

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

Split thickness skin grafting for recreation of the scrotum following Fournier's gangrene.

20 June 2024

102

1 reference

https://api.crossref.org/works/10.1097/CCM.0B013E3181EC667F

20 June 2024

Identifiers

1 reference

23 November 2017

1 reference